{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:47:10Z","timestamp":1761569230668,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Federico Fiorani charity"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clgc.2020.08.007","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T02:38:34Z","timestamp":1597286314000},"page":"237-245.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment"],"prefix":"10.1016","volume":"19","author":[{"given":"Daniele","family":"Raggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Giannatempo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Far\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Marandino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Colecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Calareso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Padovano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2020.08.007_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41572-018-0029-0","article-title":"Testicular cancer","volume":"4","author":"Cheng","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clgc.2020.08.007_bib2","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up","volume":"29","author":"Honecker","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(06)68305-0","article-title":"Testicular germ-cell cancer","volume":"367","author":"Horwich","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2020.08.007_bib4","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1200\/JCO.19.01672","article-title":"Improving the prognostic ability for personalized therapeutic approaches in nonseminomatous germ cell tumors","volume":"37","author":"Necchi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/jnci\/djq216","article-title":"Testicular cancer survivorship: research strategies and recommendations","volume":"102","author":"Travis","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clgc.2020.08.007_bib6","doi-asserted-by":"crossref","first-page":"332.e19","DOI":"10.1016\/j.urolonc.2015.04.008","article-title":"Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: implications for clinical practice, trial design, and molecular interrogation","volume":"33","author":"Raggi","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.clgc.2016.07.022","article-title":"A\u00a0suggested prognostic reclassification of intermediate and poor-risk nonseminomatous germ cell tumors","volume":"15","author":"Necchi","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2020.08.007_bib8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib9","doi-asserted-by":"crossref","unstructured":"Beyer J, Collette L, Daugaard G, et\u00a0al. Prognostic factors in advanced seminoma: an analysis from the IGCCCG Update Consortium. Paper presented at: 2020 Genitourinary Cancers Symposium; February 12-14, 2020; San Francisco, CA. Abstract n.386.","DOI":"10.1200\/JCO.2020.38.6_suppl.386"},{"key":"10.1016\/j.clgc.2020.08.007_bib10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2004.07.188","article-title":"2-18Fluoro-deoxy-d-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial","volume":"22","author":"De Santis","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/annonc\/mdr052","article-title":"2-18Fluoro-deoxy-d-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial","volume":"23","author":"Bachner","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib12","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","article-title":"Early interim 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography is prognostically superior to International Prognostic Score in advanced-stage Hodgkin\u2019s lymphoma: a report from a joint Italian\u2013Danish study","volume":"25","author":"Gallamini","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib13","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1200\/JCO.2006.06.7801","article-title":"Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction","volume":"24","author":"Ott","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib14","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1158\/1078-0432.CCR-10-2763","article-title":"Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non\u2013small cell lung cancer treated with erlotinib","volume":"17","author":"Mileshkin","year":"2011","journal-title":"Clin Cancer Res"},{"year":"2019","series-title":"EAU guidelines","author":"Laguna","key":"10.1016\/j.clgc.2020.08.007_bib15"},{"key":"10.1016\/j.clgc.2020.08.007_bib16","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1200\/JCO.2001.19.17.3740","article-title":"Predictive impact of 2-18fluoro-2-deoxy-d glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma","volume":"19","author":"De Santis","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2020.08.007_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clgc.2015.08.010","article-title":"Interim 18F-fluorodeoxyglucose positron emission tomography for early metabolic assessment of response to cisplatin, etoposide, and bleomycin chemotherapy for metastatic seminoma: clinical value and future directions","volume":"14","author":"Necchi","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2020.08.007_bib19","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00210","article-title":"Questioning the value of fluorodeoxyglucose positron emission tomography for residual lesions after chemotherapy for metastatic seminoma: results of an international global germ cell cancer group registry","author":"Cathomas","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2019.04.013","article-title":"A\u00a0phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma","volume":"115","author":"Shamash","year":"2019","journal-title":"Eur J Cancer"},{"issue":"suppl 6","key":"10.1016\/j.clgc.2020.08.007_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2020.38.6_suppl.387","article-title":"The SEMITEP trial: de-escalating chemotherapy in low-volume metastatic seminoma based on early FDG-PET","volume":"38","author":"Loriot","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib22","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.18.02057","article-title":"Developing a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrum","volume":"37","author":"Nappi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2020.08.007_bib23","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.18.01480","article-title":"Serum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study","volume":"37","author":"Dieckmann","year":"2019","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732030197X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732030197X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:33:44Z","timestamp":1761564824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155876732030197X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S155876732030197X"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2020.08.007","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2020.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}